American Portfolios Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
ACM
American Portfolios Advisors's CDLX Position: Q4 2021 in Review
American Portfolios Advisors sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 11 shares — an estimated $9.48K sold.
American Portfolios Advisors first reported a position in CDLX in Q3 2020 and held it in 5 quarters. The position peaked at $9.48K in Q3 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.
- American Portfolios Advisors reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
- American Portfolios Advisors sold 11 Cardlytics shares in Q4 2021, an estimated $9.48K.
- American Portfolios Advisors first reported a position in Cardlytics in Q3 2020 and held it in 5 quarters.
- American Portfolios Advisors's Cardlytics position peaked at $9.48K in Q3 2021.
- 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.
Based on American Portfolios Advisors's 13F filing for Q4 2021, filed 21 Mar 2023.